Barkehall-Thomas Andrea, Thompson Melanie, Baker Lesleigh S, Edwards Andrew, Wallace Euan M
Maternal-Fetal Medicine Unit, Monash Medical Centre, Southern Health, Clayton, Victoria, Australia.
Aust N Z J Obstet Gynaecol. 2003 Oct;43(5):360-3. doi: 10.1046/j.0004-8666.2003.00104.x.
It has been previously shown that glucocorticoids alter umbilical artery flow velocity waveforms in singleton pregnancies complicated by umbilical artery absent end diastolic flow. Whether similar effects are evident in multiple pregnancies where one fetus has umbilical artery absent end diastolic flow is not known.
Women with a twin or triplet pregnancy complicated by umbilical artery absent end diastolic flow in one fetus were admitted to hospital for intensive fetal surveillance including daily umbilical artery flow velocity waveform studies, as per hospital protocol. All women received prophylactic betamethasone (11.4 mg x 2, 24 h apart) in anticipation of preterm delivery.
Between October 1996 and February 2002, 24 women with a multiple pregnancy complicated by umbilical artery absent end diastolic flow were cared for. Of these, six had a pregnancy with feto-fetal transfusion and excluded from further analysis. Of the remaining 18 women, eight had monochorionic diamniotic twins, eight had dichorionic twins, and two had trichorionic, triamniotic triplets. The median (range) gestation at diagnosis of umbilical artery absent end diastolic flow was 210.5 days (173-241). In nine (50%) of the 18 pregnancies the administration of betamethasone was associated with return of umbilical artery end diastolic flow for a median of 5 days. There was no association between this effect and chorionicity. The median (range) interval from diagnosis of umbilical artery absent end diastolic flow to delivery was 11 days (1-46).
As previously reported in singleton pregnancies, the maternal administration of betamethasone in multiple pregnancies with umbilical artery absent end diastolic flow is associated with a transient return of end diastolic flow.
先前的研究表明,糖皮质激素可改变单胎妊娠合并脐动脉舒张末期血流缺失时的脐动脉血流速度波形。但尚不清楚在一个胎儿出现脐动脉舒张末期血流缺失的多胎妊娠中是否也有类似效应。
根据医院规程,单胎或三胎妊娠且其中一个胎儿出现脐动脉舒张末期血流缺失的孕妇入院接受强化胎儿监测,包括每日进行脐动脉血流速度波形研究。所有孕妇均接受预防性倍他米松治疗(11.4毫克×2次,间隔24小时),以防早产。
1996年10月至2002年2月期间,对24例多胎妊娠合并脐动脉舒张末期血流缺失的孕妇进行了护理。其中,6例妊娠合并胎儿-胎儿输血,被排除在进一步分析之外。其余18例孕妇中,8例为单绒毛膜双羊膜囊双胎,8例为双绒毛膜双胎,2例为三绒毛膜三羊膜囊三胎。诊断脐动脉舒张末期血流缺失时的孕周中位数(范围)为210.5天(173 - 241天)。在18例妊娠中的9例(50%)中,倍他米松的使用与脐动脉舒张末期血流恢复相关,中位数为5天。这种效应与绒毛膜性无关。从诊断脐动脉舒张末期血流缺失到分娩的间隔时间中位数(范围)为11天(1 - 46天)。
如先前在单胎妊娠中所报道的,在多胎妊娠合并脐动脉舒张末期血流缺失时,母体使用倍他米松与舒张末期血流的短暂恢复有关。